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Opening of Chloride Channels by 1a,25-
Dihydroxyvitamin D3 Contributes to Photoprotection
against UVR-Induced Thymine Dimers in Keratinocytes
Vanessa B. Sequeira1, Mark S. Rybchyn1, Clare Gordon-Thomson1, Wannit Tongkao-on1, Mathew T. Mizwicki2,
Anthony W. Norman2, Vivienne E. Reeve3, Gary M. Halliday4 and Rebecca S. Mason1
UVR produces vitamin D in skin, which is hydroxylated locally to 1a,25-dihydroxyvitamin D3 (1,25(OH)2D3).
1,25(OH)2D3 protects skin cells against UVR-induced DNA damage, including thymine dimers, but the mechanism
is unknown. As DNA repair is inhibited by nitric oxide (NO) products but facilitated by p53, we examined
whether 1,25(OH)2D3 altered the expression of nitrotyrosine, a product of NO, or p53 after UVR in human
keratinocytes. 1,25(OH)2D3 and the nongenomic agonist 1a,25-dihydroxylumisterol3 reduced nitrotyrosine
16hours after UVR, detected by a sensitive whole-cell ELISA. p53 was enhanced after UVR, and this was further
augmented in the presence of 1,25(OH)2D3. DIDS (4,4
0-diisothiocyanatostilbene-2,20-disulfonic acid), a chloride
channel blocker previously shown to prevent 1,25(OH)2D3-induced chloride currents in osteoblasts, had no effect
on thymine dimers on its own but prevented the 1,25(OH)2D3-induced protection against thymine dimers.
Independent treatment with DIDS, at concentrations that had no effect on thymine dimers, blocked UVR-
induced upregulation of p53. In contrast, reduction of nitrotyrosine remained in keratinocytes treated with
1,25(OH)2D3 and DIDS at concentrations shown to block decreases in post-UVR thymine dimers. These results
suggest that 1,25(OH)2D3-induced chloride currents help protect from UVR-induced thymine dimers, but further
increases in p53 or reductions of nitrotyrosine by 1,25(OH)2D3 are unlikely to contribute substantially to this
protection.
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INTRODUCTION
UVR suppresses both local and systemic immune responses
and damages DNA, inducing the formation of potentially
mutagenic photolesions. An important form of UVR-induced
DNA damage in the skin is cyclobutane pyrimidine dimers
(CPDs) (Ravanat et al., 2001), with thymine dimers being the
major subset (Rochette et al., 2003).
On the other hand, UVR, more specifically radiation from
the UVB spectrum, initiates the synthesis of vitamin D.
Exposure to sunlight converts 7-dehydrocholesterol, located
in the skin, into previtamin D, which, after thermal
isomerization at body temperature, becomes vitamin D
(Holick, 2004). This relatively inactive product requires dual
hydroxylation to form the active metabolite 1a,25-
dihydroxyvitamin D3 (1,25(OH)2D3). There is evidence that
the entire pathway to 1,25(OH)2D3 is present in epidermal
skin cells (Bikle et al., 1986; Lehmann et al., 2001).
1,25(OH)2D3 is able to exert its actions via two paths: a
classic genomic pathway that involves a vitamin D receptor in
the nucleus and results in alterations in transcription of target
genes, or a generally faster nongenomic pathway that involves
a putative membrane-associated receptor(s), which is likely to
include the nuclear vitamin D receptor, and activates a number
of intracellular signal cascades, including Akt and the opening
of chloride channels (Sequeira et al., 2009).
1,25(OH)2D3 has photoprotective effects, reducing CPD
DNA damage and apoptosis in sun-exposed skin cells (Mason
et al., 2002; De Haes et al., 2003; Gupta et al., 2007). In
osteoblasts, the nongenomic agonist of 1,25(OH)2D3 was
reported to be blocked by DIDS (4,40-diisothiocyanatostilbene-
2,20-disulfonic acid), a chloride channel inhibitor (Zanello and
Norman, 1997, 2004a). We have previously proposed that the
protective effect of 1,25(OH)2D3 on DNA damage after UVR
could depend, at least in part, on suppression of post-UVR
nitric oxide (NO) and related products (Gupta et al., 2007)
by 1,25(OH)2D3 and/or by further enhancement of p53
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expression after UVR (Dixon et al., 2005; Gupta et al., 2007).
Both a decrease in NO and an increase in p53 might be
expected to facilitate DNA repair.
The focus of this study was to investigate possible mechan-
isms involved in 1,25(OH)2D3-mediated photoprotection in
keratinocytes. In particular, we determined whether chloride
currents contribute to this activity of 1,25(OH)2D3 and used an
inhibitor of chloride currents to investigate the involvement of
1,25(OH)2D3-induced changes in p53 and nitrotyrosine, a
marker of NO and peroxynitrite (ter Steege et al., 1998; Ding
et al., 2005), after UVR, in protection from UV-induced
thymine dimers.
RESULTS
1,25(OH)2D3 reduces CPDs after UVR
We have previously reported that at time points up to 24 hours
(last time point examined) after UVR, thymine dimers, mea-
sured by image analysis after immunohistochemical staining
with an anti-thymine dimer antibody, are reduced when
1,25(OH)2D3 is added to the culture medium immediately
after UV (immediately after time zero) (Gupta et al., 2007).
As thymine dimers represent only a subset, although the
major subset, of CPDs, reduction in pyrimidine dimers by
1,25(OH)2D3 has been verified by an entirely different
approach, using a Comet assay (Collins, 2004). This assay
measures ‘‘tail moments’’ of cells (Figure 1a) resulting from
single-cell electrophoresis after digestion of DNA with T4
endonuclease V, which cuts at sites of pyrimidine dimers and
also at abasic sites, and in parallel wells, after digestion of
DNA with endonuclease IV, which cuts at abasic sites. The
CPD fraction is determined by subtracting the mean tail
moment after endonuclease IV digestion from the mean tail
moment after T4 endonuclease V digestion, as described
by others (Jiang et al., 2009). Strand breaks generated by
digestion by the specific repair enzymes form comet-like
figures, as shown in Figure 1a. The CPD fraction, calculated
from the mean tail moment of the T4 endonuclease V-sensitive
sites (CPDþ abasic sites) minus the mean tail moment of the
endonuclease IV-sensitive sites (abasic sites), was higher in the
UV-irradiated keratinocytes compared with sham (no UV).
There was no significant difference between CPD in UV
vehicle–treated cells at 3 hours compared with time zero. At
3 hours, the CPD fraction was significantly less in cells treated
with 1,25(OH)2D3 added immediately after time zero, as
compared with that in UV-irradiated vehicle–treated cells
(P¼ 0.0374; Figure 1b).
DIDS abolishes 1,25(OH)2D3-mediated protection against
thymine dimers following UVR
In this study, we used DIDS at 50mM, the lowest concentration
previously tested and shown to block 1,25(OH)2D3-induced
outwardly rectifying chloride channel currents (Mizwicki
et al., 2010), and also at 5mM. Cell viability was not affected
by these doses of DIDS (data not shown). Figure 1c shows a
significant reduction in thymine dimers when keratinocytes
were treated with 1 nM 1,25(OH)2D3 compared with vehicle-
treated cells (Po0.01). DIDS had no effect on its own
when used at 50 or 5mM compared with vehicle-treated
keratinocytes. The combination of 50mM DIDS and 1 nM
1,25(OH)2D3 was not significantly different from vehicle and
completely reversed the protective effect of 1,25(OH)2D3. The
combination of 5mM DIDS and 1 nM 1,25(OH)2D3 was not
significantly different from vehicle and partly reversed protec-
tion by 1,25(OH)2D3.
1,25(OH)2D3 and 1a,25-dihydroxylumisterol3 (JN) protect
against UVR-induced increase in nitrotyrosine
A whole-cell ELISA was developed to determine the effect of
1 nM 1,25(OH)2D3 and 1 nM JN on UVR-induced nitrotyrosine.
To verify the validity of the assay, peroxynitrite was used as a
positive control in all experiments, and a mouse IgG2b isotype
was used as a negative control. Raw absorbance values were
corrected with an IgG2b mouse isotype control to account for
nonspecific binding of the antibody, followed by correction
with Cell Titer-Blue assay to account for cell loss after UVR.
As shown in Figure 2a, there was no significant difference in
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Figure 1. 1,25(OH)2D3 reduces cyclobutane pyrimidine dimers (CPDs) after
UVR, and this effect is prevented by DIDS (4,40-diisothiocyanatostilbene-
2,20-disulfonic acid). (a) Comets shown in sham-irradiated (no UV) and
UV-irradiated keratinocytes (below) after digestion with T4 endonuclease V
(T4N5). Strand breaks produced by DNA hydrolysis with the repair enzyme
migrate in the electrophoretic field to form comet tails. DNA damage is
measured by the tail moment (% fluorescence in tail tail length) with
Tritek CometScore Freeware v1.5 (www.AutoComet.com). Bar¼ 200mm.
(b) The CPD fraction (calculated by subtracting mean tail moment of
endonuclease IV (Endo4) digests from mean tail moment of T4N5 digests) was
higher at 0 and 3 hours after UV in vehicle-treated irradiated keratinocytes
compared with unirradiated cells (no UV). The CPD fraction was reduced after
3 hours of treatment with 1,25(OH)2D3 (125D) after UV. Meanþ SEM, n¼3.
Significantly different from UV vehicle-treated at 3 hours (*P¼ 0.0374).
(c) Keratinocytes were treated immediately before irradiation with vehicle
(0.1% (v/v) DMSO), 50mM DIDS, or 5mM DIDS. After UVR, keratinocytes
were treated with vehicle (0.1% (v/v) EtOH and 0.1% (v/v) DMSO), 1 nM
1,25(OH)2D3, 50mM DIDS, 5mM DIDS, or the combination of 1,25(OH)2D3
and DIDS at the aforementioned concentrations. Thymine dimers were
detected by immunohistochemistry and image analysis 3 hours following UVR.
Mean±SEM, n¼ 4. Significantly different from vehicle, **Po0.01;
1,25(OH)2D3,
##Po0.01.
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nitrotyrosine in sham cells treated with vehicle, 1 nM
1,25(OH)2D3 or 1 nM JN. In the presence of UVR, nitrotyrosine
was significantly increased (Po0.001) compared with sham
vehicle (control cells). Nitrotyrosine levels in keratinocytes
treated with 1 nM 1,25(OH)2D3 were similar to those of sham-
irradiated cells and significantly reduced compared with UVR
vehicle (Po0.01). JN, a nongenomic analog, also reduced
nitrotyrosine (Po0.05) to a similar extent as 1,25(OH)2D3, at
the same concentration.
DIDS did not inhibit 1,25(OH)2D3-induced reduction of
nitrotyrosine after UVR
DIDS was used to determine whether chloride currents
contribute to the reduction of nitrotyrosine by 1,25(OH)2D3.
There was no significant difference in nitrotyrosine in sham
cells treated with vehicle, 1,25(OH)2D3, DIDS, or DIDSþ
1,25(OH)2D3 (Figure 2b). UVR significantly increased nitro-
tyrosine (Po0.01), and this was also seen in UVR-exposed
keratinocytes treated with DIDS alone (Po0.05), compared
with sham vehicle (control cells). In the presence of UVR,
nitrotyrosine levels in keratinocytes treated with 1,25(OH)2D3
alone or DIDSþ1,25(OH)2D3 were not significantly different
from sham-irradiated cells. Thus, the presence of DIDS did not
reduce the effectiveness of 1,25(OH)2D3 in decreasing nitro-
tyrosine after UVR.
UVR-induced increase in p53 is further augmented by
1,25(OH)2D3
As shown in Figure 3a, there was no difference in p53
expression in sham-irradiated keratinocytes treated with vehi-
cle compared with 1 nM 1,25(OH)2D3, as measured by whole-
cell ELISA. Exposure to UVR significantly augmented p53
expression in human keratinocytes (Po0.001) compared with
sham vehicle (control cells), and this was further enhanced in
UVR-exposed keratinocytes treated with 1 nM 1,25(OH)2D3
(Po0.001).
DIDS, on its own, reduced p53 expression after UVR
As shown in Figure 3b, there was no significant difference
in p53 expression in sham-irradiated keratinocytes treated
with vehicle compared with sham 1 nM 1,25(OH)2D3,
sham 50 mM DIDS, or sham DIDSþ 1,25(OH)2D3. After
UVR, independent treatment with DIDS significantly
reduced p53 to 71% of vehicle (Po0.001), values not
significantly different from those seen in sham-irradiated
cells. There was no significant difference in p53 expression
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Figure 2. 1,25(OH)2D3 and 1a,25-dihydroxylumisterol3(JN) reduce
UVR-induced nitrotyrosine, and this is not prevented by DIDS (4,40-
diisothiocyanatostilbene-2,20-disulfonic acid). Keratinocytes were unexposed
(sham) or exposed to UVR and treated with (a) vehicle (0.1% (v/v) EtOH), 1 nM
1,25(OH)2D3, or 1 nM JN immediately after irradiation or (b) treated before
irradiation with vehicle (0.1% (v/v) DMSO) or 50mM DIDS and immediately
after irradiation with vehicle (0.1% (v/v) EtOH and 0.1% (v/v) DMSO), 1 nM
1,25(OH)2D3, 50mM DIDS, or the combination of 1 nM 1,25(OH)2D3 and 50mM
DIDS. Nitrotyrosine was detected by whole-cell ELISA 16 hours after UVR.
Individual absorbance values were corrected for cell viability by Cell Titer-Blue
assay before pooling. Mean±SEM, n¼5. Significantly different from sham
vehicle, ***Po0.001, **Po0.01, *Po0.05; UVR vehicle, ##Po0.01,
#Po0.05.
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Figure 3. DIDS (4,40-diisothiocyanatostilbene-2,20-disulfonic acid) prevents
UVR- and 1a,25-dihydroxyvitamin D3 (1,25(OH)2D3)-induced increase in
p53 expression. Human keratinocytes were unexposed (sham) or exposed to
UVR and (a) treated immediately after with vehicle (0.1% (v/v) EtOH) or 1 nM
1,25(OH)2D3 or (b) treated before irradiation with vehicle (0.1% (v/v) DMSO)
or 50mM DIDS and immediately after irradiation with vehicle (0.1% (v/v) EtOH
and 0.1% (v/v) DMSO), 1 nM 1,25(OH)2D3, 50mM DIDS, or the combination of
1 nM 1,25(OH)2D3 and 50mM DIDS. p53 was detected by whole-cell ELISA
6 hours after UVR. Individual absorbance values were corrected for cell
viability by Cell Titer-Blue assay before pooling. Average sham vehicle
absorbance values were 0.22. Mean±SEM, n¼ 5. Significantly different from
sham vehicle, ***Po0.001; UVR vehicle, YYYPo0.001, YYPo0.01; UVR
1,25(OH)2D3,
OOOPo0.001.
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in irradiated keratinocytes treated with DIDS compared
with DIDSþ1,25(OH)2D3.
DISCUSSION
In this study, we have extended previous work to show that
1,25(OH)2D3 also reduces UVR-induced CPDs measured by
the comet assay, as well as the previously demonstrated
reduction in thymine dimers assessed by immunohistochem-
istry followed by image analysis. We have previously reported
that these photoprotective effects of 1,25(OH)2D3 against
UVR-induced thymine dimers and apoptosis are most likely
mediated through the nongenomic pathway (Wong et al.,
2004; Dixon et al., 2005, 2007). However, the mechanism of
this effect is poorly understood.
DIDS has been described in many previous reports to inhibit
chloride channel activity in skin cells including keratinocytes
(Mastrocola et al., 1991; Kansen et al., 1992; Wohlrab et al.,
2000; Koegel and Alzheimer, 2001; Zholos et al., 2005;
Raoux et al., 2007). Furthermore, there is strong evidence
from multiple studies in osteoblast-like rat osteosarcoma cells
and also TM4 Sertoli cells that the nongenomic effect of
1,25(OH)2D3 in enhancing outwardly rectifying chloride
channel currents is blocked by DIDS (Zanello and Norman,
1996, 1997, 2003, 2004b; Mizwicki et al., 2010). In this
study, 50mM DIDS on its own had no effect on thymine
dimers, but it completely reversed the effect of 1,25(OH)2D3
in reducing thymine dimers following UVR exposure in
keratinocytes. DIDS at 5mM partly prevented the protective
effect of 1,25(OH)2D3 against thymine dimers. It is therefore
likely that opening of chloride channels by 1,25(OH)2D3
contributes to photoprotection against UVR-induced thymine
dimers in keratinocytes.
UVR induces production of reactive nitrogen species,
including NO, and reactive oxygen species, including super-
oxide radicals, in skin cells (Deliconstantinos et al., 1996;
Bruch-Gerharz et al., 1998; Chang et al., 2003; Aitken et al.,
2007). Although NO is increased within minutes after UVR
treatment in HaCaT cells, these are not primary keratinocytes
(Aitken et al., 2007). A much longer time course of several
hours (6–24 hours) has been reported for UVR induction of
inducible NO synthase and NO in human epidermal
keratinocytes (Kuhn et al., 1998; Sasaki et al., 2000).
Nitrotyrosine is likely to take even longer to detect than
NO, as it is downstream of NO and may increase only after
other protective mechanisms have been overwhelmed. Later
detection of changes in nitrotyrosine is a marker for earlier and
more subtle increases in NO and peroxynitrite (ter Steege
et al., 1998; Ding et al., 2005). Preliminary analysis using a
sensitive whole-cell ELISA showed that the UVR-induced
increase in nitrotyrosine was evident at 4 hours after UVR,
maximal at 16 hours after UVR (the next time point examined),
and remained in cells, but at a lower level, at 24 hours (data
not shown).
Previous studies in our laboratory used the Greiss assay and
reported a small reduction in UVR-induced nitrite, a product
of NO, by 1,25(OH)2D3 in keratinocytes, to a level similar to
the reduction seen following treatment with the NO synthase
inhibitors, aminoguanidine and L-N-monomethylarginine
(Gupta et al., 2007). However, nitrite was detected by
the relatively insensitive Griess reaction. In this study,
treatment with 1,25(OH)2D3 completely protected against
UVR-induced increase in nitrotyrosine. As JN, an analog that
is only capable of acting through the nongenomic pathway,
reduced UVR-induced nitrotyrosine to a similar extent as
1,25(OH)2D3, it seems likely that the 1,25(OH)2D3-asso-
ciated decrease in nitrotyrosine occurs via a nongenomic
pathway for 1,25(OH)2D3.
NO preferentially inhibits the excision and ligation steps
during nucleotide excision repair (Bau et al., 2001) and
directly damages DNA (Ohshima et al., 2006). It therefore
seemed plausible at the beginning of these studies that protec-
tion against UVR-induced NO products by 1,25(OH)2D3
contributed to the photoprotective mechanism of 1,25-
(OH)2D3 in reducing CPD DNA damage after UVR. It is clear
that 1,25(OH)2D3-induced upregulation of chloride currents
is crucial in the reduction of thymine dimers, yet treatment
of keratinocytes with the combination of DIDS and 1,25-
(OH)2D3, at the same concentration of DIDS that abolished
protection against thymine dimers, did not prevent the
reduction in nitrotyrosine by 1,25(OH)2D3. These results do
not support previous hypotheses that 1,25(OH)2D3-induced
reduction of NO products is essential to the mechanism by
which 1,25(OH)2D3 attenuates thymine dimers. However, reduc-
tion of NO products by 1,25(OH)2D3 may still be involved in
reducing oxidative damage and abasic sites after UVR.
Results presented here using a whole-cell ELISA for p53
expression extend a previous study by our group describing
upregulation of nuclear p53 after UVR, which is further
enhanced in the presence of 1,25(OH)2D3, as measured by
immunohistochemistry and image analysis (Gupta et al.,
2007). We also previously reported that the nongenomic cis-
locked analog, JN, increased p53 in skin cells, supporting the
proposal that this is a nongenomic effect of 1,25(OH)2D3
(Dixon, 2008). p53 initiates growth arrest once damaged
DNA has been detected, but this would be of limited use if
DNA lesions in cells were not repaired before replication.
One mechanism by which p53 promotes repair is through
regulation of the growth arrest and DNA damage gene,
GADD45, which directly associates with UVR-damaged
DNA (Carrier et al., 1999). In fact, it has been shown that
1,25(OH)2D3 also induces GADD45a in mouse head and
neck squamous cell carcinoma cells in vivo (Akutsu et al.,
2001). In addition, p53 controls XPC and DDB2 proteins, both
of which are involved in nucleotide excision repair, the primary
repair mechanism for CPDs. These DNA-binding proteins
recognize lesions in the DNA sequence (Hwang et al., 1999;
Smith and Seo, 2002). For these reasons it was hypothesized
that increased p53 expression by 1,25(OH)2D3 likely contri-
butes to enhanced repair of UVR-induced thymine dimers.
In this study, independent treatment of keratinocytes with
DIDS significantly reduced the UVR-induced increase in p53,
suggesting that UVR-induced increase in p53 requires a
chloride flux. If elevated p53 were involved in thymine dimer
repair, then we would expect to see an increase in post-UVR
thymine dimers when keratinocytes were treated with DIDS,
compared with vehicle. However, DIDS on its own had no
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effect on thymine dimers after UVR (Figure 1). The involve-
ment of p53 in repair of thymine dimers cannot be ruled out
completely, but if increases in p53 contribute to photoprotec-
tion it is clearly not sufficient for full photoprotection. This is
supported by a recent paper that shows extensive tolerance of
a large accumulation of persistent nonsynonymous p53 muta-
tions in normal skin exposed to UVR (Stahl et al., 2011). In
addition, XPC and DDB2 expression levels, as well as the
global genome repair pathway of nucleotide excision repair of
CPDs, were maintained after UVR in human keratinocytes
expressing human papilloma type 16 E6 and E7 oncoproteins,
and which are therefore p53 deficient (Ferguson and Oh,
2005). Similarly, normal global genome repair of CPDs after
UVR remained in normal keratinocytes treated with pifithrin-
a, a chemical inhibitor of p53, and in SCC25 cells, which
express mutations in p53, attenuating the mRNA and protein
levels of p53 (Ferguson and Oh, 2005). It was therefore
postulated that p63, a p53 homolog, may function to
regulate global genome repair in keratinocytes in place of
p53. Targeted knockdown of p63 in E6/E7 keratinocytes,
which are p53 deficient, was associated with attenuated
DDB2 and XPC protein levels and impaired global genome
repair of CPDs, whereas XPC and DDB2 mRNA levels were
not altered (Ferguson-Yates et al., 2008). These results suggest
that p63 is critical for global genome repair of CPDs in
keratinocytes that lack p53.
Chloride currents appear to be a general feature of vitamin
D nongenomic pathways, and the data in this study implicate
chloride currents as one essential component in the mechan-
ism by which 1,25(OH)2D3 reduces thymine dimers in
keratinocytes. The results also indicate that the post-UV
reduction of NO products or further upregulation of p53 by
1,25(OH)2D3 is not essential for photoprotection against
thymine dimers. As protection by vitamin D compounds is
observed as a reduction in photocarcinogenesis (Mason et al.,
2011), elucidation of mechanisms for this effect is necessary.
MATERIALS AND METHODS
The studies of human tissue were approved by the Human Research
Ethics Committee of the University of Sydney and Sydney South West
Area Health Service Human Ethics Committee and were conducted
according to the Declaration of Helsinki Principles. All subjects or
their legal guardians gave written informed consent. Human neonatal
foreskin samples were cultured for the processing of keratinocytes
as described previously by Gupta et al. (2007). The growth medium
used was Gibco DMEM (Grand Island, NY) with reduced calcium
(purchased from Invitrogen, Grand Island, NY) to prevent keratinocyte
differentiation (Bikle et al., 1996; Daniels et al., 1996), with 2 mM
glutamine, 8.4 mM HEPES, and 5% (v/v) fetal bovine serum, and with
additional supplements: 10mg l 1 epidermal growth factor, 0.1 nM
cholera toxin, and 1.38mM hydrocortisone. Keratinocytes, at passages
1–5, were seeded onto 5 mm poly-L-lysine-coated glass coverslips in
96-well plates at a density of 25,000 cells per well for immunohis-
tochemical studies. For whole-cell ELISA experiments, keratinocytes
were plated at a density of 15,000 cells per well in 96-well plates.
Cells were plated in quadruplicate wells for each treatment. Twenty-
four hours before irradiation, the growth medium was replaced with
medium without the supplements: epidermal growth factor, cholera
toxin, and hydrocortisone, to normalize the cell signaling pathways
(McLeod et al., 1995). Where relevant, keratinocytes were treated
with an inhibitor diluted in Martinez buffer (145 mM NaCl, 5.5 mM
KCl, 1.2 mM MgCl2.6H2O, 1.2 mM NaH2PO4.2H20, 7.5 mM HEPES,
1 mM CaCl2.2H20, 10 mM D-glucose) immediately before irradiation.
Cells were irradiated using a UVA and UVB fluorescent lamp (NEC,
Tokyo, Japan and Phillips, Eindhoven, Holland, respectively), with a
total of 203 mJ cm 2 UVB and 1,169 mJ cm 2 UVA. Output char-
acteristics have been previously published (Gupta et al., 2007), and
the spectrum of the UVA and UVB lamps compared with sunlight is
provided in Supplementary Figure S1 online. UV light was filtered
through a cellulose triacetate sheet (Eastman Chemical Products,
Kingsport, TN) to eliminate wavelengths below 290 nm. All cells were
treated identically throughout the procedure; however, the sham plate
was shielded during irradiation. Immediately after UVR, Martinez
buffer was replaced with supplement-free medium with a similar
composition to the medium used before irradiation but containing
treatments including inhibitors. The compounds used in these studies
were 1,25(OH)2D3 (Cayman Chemical, Ann Arbor, MI), JN, and
DIDS, a chloride channel blocker (Sigma-Aldrich, St Louis, MO).
Comet assay
The comet assay was performed following the steps that were
previously described (Javeri et al., 2011) using reagents provided in
a kit purchased from Trevigen, Gaithersburg, MD. In brief, cell
suspensions at a density of 5,000 cells ml 1 were embedded in 1%
low-melting-point agarose in three wells/FLARE slide (R&D Systems,
Minneapolis, MN). Replicates were digested at 37 1C for 30 minutes
in either T4 endonuclease V/T4-pyrimidine dimer glycosylase (R&D
Systems) or endonuclease IV (New England Biolabs, Ipswich, MA)
diluted 1:1,000 in reaction buffer, or without enzyme (negative
controls). DNA breaks were exposed by unwinding in alkali
solution (30 mM NaCl; 1 mM EDTA, pH 12.1) for 30 minutes at
room temperature. Strand breaks were separated by electrophoresis
and comets visualized by SYBR Green 1 staining. Images were
captured using a Nikon E800 epifluorescence microsope (Melville,
NY) and the Leica image analysis software (North Ryde, NSW,
Australia). DNA damage was measured by the extent of migration
of the single-strand breaks (tail length) and the relative amount of
DNA in the tail (fluorescent intensity) to produce the tail moment (%
fluorescence in tail tail length) using Tritek CometScore Freeware
v1.5 (www.AutoComet.com). The mean tail moment of 100 comets
per slide was corrected for extraneous DNA damage produced during
processing by subtracting the mean tail moment of an undigested
sample (no enzyme negative control) from the mean tail moment of
the digested replicate sample.
Immunohistochemistry
For detection of thymine dimers, keratinocytes were fixed 3 hours
after irradiation. Immunohistochemistry and image analysis were
performed as described previously by Gupta et al. (2007), except
that cells were blocked with 50% (v/v) horse serum in phosphate-
buffered saline (PBS) and four images were captured for each UV-
irradiated coverslip.
Whole-cell ELISA
For whole-cell ELISA, keratinocytes were plated and subjected to
irradiation and then treated as indicated above. For the nitrotyrosine
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and p53 ELISAs, peroxynitrite (Cayman Chemical) (Reiter et al., 2000)
and sodium arsenite (Sigma-Aldrich) (Yih and Lee, 2000),
respectively, were used as positive controls to validate the assays.
Cells were briefly rinsed with 100ml of PBS. Fixation of cells with
3.7% (v/v) formaldehyde in PBS for 10 minutes at room temperature
occurred at 16 hours after UVR for detection of nitrotyrosine and at
6 hours after UVR for the detection of p53 (Gupta et al., 2007). The
cells were washed three times with 0.1% (v/v) Triton X-100 in PBS on
the plate shaker for 2 minutes at room temperature to permeabalize
the membrane. One percent (v/v) H2O2 in PBS was applied to quench
endogenous peroxidases before the cells were incubated with a
blocker (10% (v/v) fetal bovine serum in PBS) for 1 hour at room
temperature. For the detection of nitrotyrosine, cells were incubated
with 2mg ml 1 mouse monoclonal IgG2b nitrotyrosine primary
antibody (Abcam, Cambridge, UK) diluted in blocker. For p53
detection, cells were incubated with 4mg ml 1 rabbit polyclonal
IgG p53 primary antibody (Santa Cruz Biotechnology, Santa Cruz,
CA) or mouse monoclonal IgG p53 primary antibody (Cell Signaling
Technology, Danvers, MA) diluted in blocker, overnight at 4 1C as
previously described (Sequeira et al., 2012). For the nitrotyrosine
ELISA, 2mg ml 1 mouse IgG2b isotype and for the p53 ELISA
4mg ml 1 rabbit IgG isotype or mouse IgG isotype (R&D Systems)
were added to the negative control wells for incubation overnight at
4 1C. On the following day, cells were incubated with 0.2mg ml 1
goat anti-mouse IgG-HRP (Cell Signaling Technology, Beverly, MA)
or 0.16mg ml 1 goat anti-rabbit IgG-HRP (Santa Cruz Biotechnology)
secondary antibody diluted in blocker for 1 hour at room temperature.
Cells were washed three times with PBS and then three times with
citrate phosphate buffer (50 mM citric acid and 100 mM NaH2PO4, pH
5). Color development was initiated by the addition of citrate
phosphate buffer containing 0.1 mg ml 1 3,30,5,50-tetramethylbenzi-
dine and 0.015% (v/v) H2O2. The substrate was allowed to develop
for 30–40 minutes at room temperature before being stopped by
the addition of 0.5 volumes of 2 M H2SO4. Binding of the nitrotyrosine
antibody or the p53 antibody was determined by reading the
absorbance at 450 nm on a Polarstar Galaxy microplate reader
(BMG Labtech Pty, Victoria, Australia). As shown in Supplementary
Figure S2 online, nitrotyrosine detection by whole-cell ELISA was
proportional to the concentration of exogenous peroxynitrite added
(Supplementary Figure S2a online) and with UV dose up to
203 mJ cm 2 UVB and 1,169 mJ cm 2 UVA (Supplementary Figure
S2b online). As shown in Supplementary Figure S3 online, p53
increased with increasing arsenite (Supplementary Figure S3a online)
and after UV exposure (Supplementary Figure S3b online). Unless
otherwise stated, the different stages of the whole-cell ELISA were
separated by washing the cells three times with 0.1% (v/v) Tween-20
in PBS. Raw absorbance values were corrected with the isotype
control to account for nonspecific binding of the antibody.
At the time of fixation, a Cell Titer-Blue assay (Promega, Madison,
WI) was performed according to the manufacturer’s recommenda-
tions to correct for the number of viable cells, and then a bicinch-
oninic acid assay (Pierce Chemical, Rockford, IL) was performed
according to the manufacturer’s instructions to correct for total cell
protein. These two assays were carried out on identically treated
wells. It was necessary to correct for cell viability or total cell protein,
as there was a significant decrease in the number of cells following
UVR exposure compared with sham-irradiated cells. Although a cell
viability assay such as Cell Titer-Blue is not commonly used as a
correction method, it was reasonable to use it in the current studies
using primary human keratinocyte cultures, as the Cell Titer-Blue
assay is a more sensitive assay compared with the bicinchoninic
acid assay for cultures with low cell number (Bruno et al., 2004).
Results showed a similar qualitative trend when absorbance
values were corrected with the bicinchoninic acid or Cell
Titer-Blue assays.
Statistical analysis
All experiments were repeated a minimum of three times, with three
different donors, showing similar results on each occasion. Pooled
data are presented as normalized results from a minimum of three
independent experiments. In each ELISA experiment, values were
based on quadruplicate or quintuplicate wells. Significant differences
between treatment groups were determined by one-way analysis of
variance followed by the Newman–Keuls test using the GraphPad
Instat statistical program (GraphPad Software, San Diego, CA). In
each comet assay, values were based on replicates of 100 comets per
slide. Significant differences between treatment groups were deter-
mined by an unpaired t-test with Welch correction using the
GraphPad Instat statistical program.
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